DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies

Abstract

A preventive HIV-1 vaccine should induce HIV-1–specific broadly neutralizing antibodies (bnAbs). However, bnAbs generally require high levels of somatic hypermutation (SHM) to acquire breadth, and current vaccine strategies have not been successful in inducing bnAbs. Because bnAbs directed against a glycosylated site adjacent to the third variable loop (V3) of the HIV-1 envelope protein require limited SHM, the V3-glycan epitope is an attractive vaccine target. By studying the cooperation among multiple V3-glycan B cell lineages and their coevolution with autologous virus throughout 5 years of infection, we identify key events in the ontogeny of a V3- glycan bnAb. Two autologous neutralizing antibody lineages selected for virus escape mutations and consequently allowed initiation and affinity maturation of a V3-glycan bnAb lineage. The nucleotide substitution required to initiate the bnAb lineage occurred at a low-probability site for activation-induced cytidine deaminase activity. Cooperation of B cell lineages and an improbable mutation critical for bnAb activity defined the necessary events leading to breadth in this V3- glycan bnAb lineage. These findings may, in part, explain why initiation of V3-glycan bnAbs is rare, and suggest an immunization strategy for inducing similar V3-glycan bnAbs.

Authors:
ORCiD logo [1]; ORCiD logo [2]; ORCiD logo [3]; ORCiD logo [1]; ORCiD logo [1]; ORCiD logo [1]; ORCiD logo [1]; ORCiD logo [4]; ORCiD logo [4]; ORCiD logo [5];  [6]; ORCiD logo [5];  [5]; ORCiD logo [5];  [5];  [5];  [5]; ORCiD logo [7];  [7];  [7] more »;  [3];  [3]; ORCiD logo [1]; ORCiD logo [1]; ORCiD logo [8];  [9];  [10];  [11]; ORCiD logo [12]; ORCiD logo [10];  [1]; ORCiD logo [5];  [1]; ORCiD logo [13]; ORCiD logo [1]; ORCiD logo [1];  [4]; ORCiD logo [7];  [2];  [2];  [3]; ORCiD logo [10]; ORCiD logo [1] « less
  1. Duke Univ. School of Medicine, Durham, NC (United States); Duke Human Vaccine Inst., Durham, NC (United States)
  2. Univ. of Pennsylvania, Philadelphia, PA (United States). Perelman School of Medicine
  3. Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States)
  4. Memorial Sloan Kettering Cancer Center, New York, NY (United States)
  5. Duke Human Vaccine Inst., Durham, NC (United States)
  6. Duke Human Vaccine Inst., Durham, NC (United States); Duke Univ. Schoole of Medicine, Durham, NC (United States)
  7. National Inst. of Health (NIH), Bethesda, MD (United States)
  8. National Inst. of Communicable Diseases, Johannesburg (South Africa)
  9. Univ. of Alabama, Burmingham, AL (United States)
  10. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  11. Kamuzu Central Hospital, Lilongwe (Malawi). Univ. of North Carolina Project
  12. Univ. of North Carolina, Chapel Hill, NC (United States)
  13. Boston Univ., MA (United States)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
National Institutes of Health (NIH); USDOE
OSTI Identifier:
1406204
Report Number(s):
LA-UR-16-25421
Journal ID: ISSN 1946-6234
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
Science Translational Medicine
Additional Journal Information:
Journal Volume: 9; Journal Issue: 381; Journal ID: ISSN 1946-6234
Publisher:
AAAS
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; Biological Science

Citation Formats

Bonsignori, Mattia, Kreider, Edward F., Fera, Daniela, Meyerhoff, R. Ryan, Bradley, Todd, Wiehe, Kevin, Alam, S. Munir, Aussedat, Baptiste, Walkowicz, William E., Hwang, Kwan-Ki, Saunders, Kevin O., Zhang, Ruijun, Gladden, Morgan A., Monroe, Anthony, Kumar, Amit, Xia, Shi-Mao, Cooper, Melissa, Louder, Mark K., McKee, Krisha, Bailer, Robert T., Pier, Brendan W., Jette, Claudia A., Kelsoe, Garnett, Williams, Wilton B., Morris, Lynn, Kappes, John, Wagh, Kshitij, Kamanga, Gift, Cohen, Myron S., Hraber, Peter T., Montefiori, David C., Trama, Ashley, Liao, Hua-Xin, Kepler, Thomas B., Moody, M. Anthony, Gao, Feng, Danishefsky, Samuel J., Mascola, John R., Shaw, George M., Hahn, Beatrice H., Harrison, Stephen C., Korber, Bette T., and Haynes, Barton F. Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies. United States: N. p., 2017. Web. doi:10.1126/scitranslmed.aai7514.
Bonsignori, Mattia, Kreider, Edward F., Fera, Daniela, Meyerhoff, R. Ryan, Bradley, Todd, Wiehe, Kevin, Alam, S. Munir, Aussedat, Baptiste, Walkowicz, William E., Hwang, Kwan-Ki, Saunders, Kevin O., Zhang, Ruijun, Gladden, Morgan A., Monroe, Anthony, Kumar, Amit, Xia, Shi-Mao, Cooper, Melissa, Louder, Mark K., McKee, Krisha, Bailer, Robert T., Pier, Brendan W., Jette, Claudia A., Kelsoe, Garnett, Williams, Wilton B., Morris, Lynn, Kappes, John, Wagh, Kshitij, Kamanga, Gift, Cohen, Myron S., Hraber, Peter T., Montefiori, David C., Trama, Ashley, Liao, Hua-Xin, Kepler, Thomas B., Moody, M. Anthony, Gao, Feng, Danishefsky, Samuel J., Mascola, John R., Shaw, George M., Hahn, Beatrice H., Harrison, Stephen C., Korber, Bette T., & Haynes, Barton F. Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies. United States. https://doi.org/10.1126/scitranslmed.aai7514
Bonsignori, Mattia, Kreider, Edward F., Fera, Daniela, Meyerhoff, R. Ryan, Bradley, Todd, Wiehe, Kevin, Alam, S. Munir, Aussedat, Baptiste, Walkowicz, William E., Hwang, Kwan-Ki, Saunders, Kevin O., Zhang, Ruijun, Gladden, Morgan A., Monroe, Anthony, Kumar, Amit, Xia, Shi-Mao, Cooper, Melissa, Louder, Mark K., McKee, Krisha, Bailer, Robert T., Pier, Brendan W., Jette, Claudia A., Kelsoe, Garnett, Williams, Wilton B., Morris, Lynn, Kappes, John, Wagh, Kshitij, Kamanga, Gift, Cohen, Myron S., Hraber, Peter T., Montefiori, David C., Trama, Ashley, Liao, Hua-Xin, Kepler, Thomas B., Moody, M. Anthony, Gao, Feng, Danishefsky, Samuel J., Mascola, John R., Shaw, George M., Hahn, Beatrice H., Harrison, Stephen C., Korber, Bette T., and Haynes, Barton F. Wed . "Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies". United States. https://doi.org/10.1126/scitranslmed.aai7514. https://www.osti.gov/servlets/purl/1406204.
@article{osti_1406204,
title = {Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies},
author = {Bonsignori, Mattia and Kreider, Edward F. and Fera, Daniela and Meyerhoff, R. Ryan and Bradley, Todd and Wiehe, Kevin and Alam, S. Munir and Aussedat, Baptiste and Walkowicz, William E. and Hwang, Kwan-Ki and Saunders, Kevin O. and Zhang, Ruijun and Gladden, Morgan A. and Monroe, Anthony and Kumar, Amit and Xia, Shi-Mao and Cooper, Melissa and Louder, Mark K. and McKee, Krisha and Bailer, Robert T. and Pier, Brendan W. and Jette, Claudia A. and Kelsoe, Garnett and Williams, Wilton B. and Morris, Lynn and Kappes, John and Wagh, Kshitij and Kamanga, Gift and Cohen, Myron S. and Hraber, Peter T. and Montefiori, David C. and Trama, Ashley and Liao, Hua-Xin and Kepler, Thomas B. and Moody, M. Anthony and Gao, Feng and Danishefsky, Samuel J. and Mascola, John R. and Shaw, George M. and Hahn, Beatrice H. and Harrison, Stephen C. and Korber, Bette T. and Haynes, Barton F.},
abstractNote = {A preventive HIV-1 vaccine should induce HIV-1–specific broadly neutralizing antibodies (bnAbs). However, bnAbs generally require high levels of somatic hypermutation (SHM) to acquire breadth, and current vaccine strategies have not been successful in inducing bnAbs. Because bnAbs directed against a glycosylated site adjacent to the third variable loop (V3) of the HIV-1 envelope protein require limited SHM, the V3-glycan epitope is an attractive vaccine target. By studying the cooperation among multiple V3-glycan B cell lineages and their coevolution with autologous virus throughout 5 years of infection, we identify key events in the ontogeny of a V3- glycan bnAb. Two autologous neutralizing antibody lineages selected for virus escape mutations and consequently allowed initiation and affinity maturation of a V3-glycan bnAb lineage. The nucleotide substitution required to initiate the bnAb lineage occurred at a low-probability site for activation-induced cytidine deaminase activity. Cooperation of B cell lineages and an improbable mutation critical for bnAb activity defined the necessary events leading to breadth in this V3- glycan bnAb lineage. These findings may, in part, explain why initiation of V3-glycan bnAbs is rare, and suggest an immunization strategy for inducing similar V3-glycan bnAbs.},
doi = {10.1126/scitranslmed.aai7514},
journal = {Science Translational Medicine},
number = 381,
volume = 9,
place = {United States},
year = {Wed Mar 15 00:00:00 EDT 2017},
month = {Wed Mar 15 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 119 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Structure and immune recognition of trimeric pre-fusion HIV-1 Env
journal, October 2014

  • Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr
  • Nature, Vol. 514, Issue 7523
  • DOI: 10.1038/nature13808

Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans
journal, December 2015


Broad neutralization coverage of HIV by multiple highly potent antibodies
journal, September 2011

  • Walker, Laura M.; Huber, Michael; Doores, Katie J.
  • Nature, Vol. 477, Issue 7365
  • DOI: 10.1038/nature10373

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
journal, March 2016


Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
journal, June 2014

  • Fera, D.; Schmidt, A. G.; Haynes, B. F.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 28
  • DOI: 10.1073/pnas.1409954111

HIV Transmission
journal, October 2012


HIV-1 neutralizing antibodies: understanding nature's pathways
journal, June 2013

  • Mascola, John R.; Haynes, Barton F.
  • Immunological Reviews, Vol. 254, Issue 1
  • DOI: 10.1111/imr.12075

Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors
journal, October 2013

  • Alam, S. M.; Dennison, S. M.; Aussedat, B.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 45
  • DOI: 10.1073/pnas.1317855110

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
journal, October 2012

  • Moore, Penny L.; Gray, Elin S.; Wibmer, C. Kurt
  • Nature Medicine, Vol. 18, Issue 11
  • DOI: 10.1038/nm.2985

HIV-Specific Probabilistic Models of Protein Evolution
journal, June 2007


Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
journal, October 2010


A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
journal, September 2013


Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design
journal, February 2012

  • Bonsignori, Mattia; Montefiori, David C.; Wu, Xueling
  • Journal of Virology, Vol. 86, Issue 8
  • DOI: 10.1128/JVI.07163-11

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
journal, June 2009

  • Salazar-Gonzalez, Jesus F.; Salazar, Maria G.; Keele, Brandon F.
  • The Journal of Experimental Medicine, Vol. 206, Issue 6
  • DOI: 10.1084/jem.20090378

Chemical Synthesis of Highly Congested gp120 V1V2 N -Glycopeptide Antigens for Potential HIV-1-Directed Vaccines
journal, August 2013

  • Aussedat, Baptiste; Vohra, Yusuf; Park, Peter K.
  • Journal of the American Chemical Society, Vol. 135, Issue 35
  • DOI: 10.1021/ja405990z

Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV
journal, May 2014


Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
journal, November 2009

  • Seaman, M. S.; Janes, H.; Hawkins, N.
  • Journal of Virology, Vol. 84, Issue 3
  • DOI: 10.1128/JVI.02108-09

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
journal, April 2013

  • Liao, Hua-Xin; Lynch, Rebecca; Zhou, Tongqing
  • Nature, Vol. 496, Issue 7446
  • DOI: 10.1038/nature12053

Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots.
journal, March 1993

  • Betz, A. G.; Rada, C.; Pannell, R.
  • Proceedings of the National Academy of Sciences, Vol. 90, Issue 6
  • DOI: 10.1073/pnas.90.6.2385

Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
journal, April 2016


Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
journal, May 2008

  • Keele, B. F.; Giorgi, E. E.; Salazar-Gonzalez, J. F.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 21
  • DOI: 10.1073/pnas.0802203105

High throughput functional analysis of HIV-1 env genes without cloning
journal, July 2007


Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy
journal, October 2015


Antibody responses to envelope glycoproteins in HIV-1 infection
journal, May 2015

  • Burton, Dennis R.; Mascola, John R.
  • Nature Immunology, Vol. 16, Issue 6
  • DOI: 10.1038/ni.3158

Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes
journal, November 2015


Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
journal, July 2014


Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
journal, September 2009


Models of Somatic Hypermutation Targeting and Substitution Based on Synonymous Mutations from High-Throughput Immunoglobulin Sequencing Data
journal, January 2013


Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
journal, October 2015

  • Hraber, Peter; Korber, Bette; Wagh, Kshitij
  • Viruses, Vol. 7, Issue 10
  • DOI: 10.3390/v7102881

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
journal, October 2012

  • Mouquet, H.; Scharf, L.; Euler, Z.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 47
  • DOI: 10.1073/pnas.1217207109

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
journal, October 2011


Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
journal, July 2015


The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
journal, November 2013


Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies
journal, September 2014


B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
journal, May 2012

  • Haynes, Barton F.; Kelsoe, Garnett; Harrison, Stephen C.
  • Nature Biotechnology, Vol. 30, Issue 5
  • DOI: 10.1038/nbt.2197

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
journal, May 2013

  • Kong, Leopold; Lee, Jeong Hyun; Doores, Katie J.
  • Nature Structural & Molecular Biology, Vol. 20, Issue 7
  • DOI: 10.1038/nsmb.2594

Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations
journal, March 2007


Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
journal, March 2017


Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
text, January 2009

  • S., Perelson, Alan; Christina, Ochsenbauer-Jambor,; C., Kappas, John
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/1n1a-3d64

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
text, January 2017

  • Hua-Xin, Liao,; R., Mascola, John; Amanda, Eaton,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/8pms-aw04

Structure and immune recognition of trimeric pre-fusion HIV-1 Env
text, January 2014

  • B., Munro, James; Lynn, Morris,; Tongqing, Zhou,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/bt86-bx50

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
text, January 2013

  • Jenny, McDowell,; Quino, Maduro,; Jiang, Zhu,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/krmn-eg43

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
text, January 2008

  • F., Salazar-Gonzalez, Jesus; P., Busch, Michael; S., Perelson, Alan
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/f6s9-vz03

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
text, January 2009

  • Joseph, Mulenga,; G., Salazar, Maria; Susan, Allen,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/gak8-9b11

Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
text, January 2014

  • F., Haynes, Barton; M., Lynch, Rebecca; Xiaozhi, Lu,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/8am4-5r40

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
text, January 2012

  • Tandile, Hermanus,; Abdool, Karim, Quarraisha; E., Lambson, Bronwen
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/e8bk-6082

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
text, January 2010

  • Hongmei, Gao,; Tanmoy, Bhattacharya,; S., Cohen, Myron
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/py3f-pj09

Works referencing / citing this record:

OUTRIDER: A Statistical Method for Detecting Aberrantly Expressed Genes in RNA Sequencing Data
journal, December 2018

  • Brechtmann, Felix; Mertes, Christian; Matusevičiūtė, Agnė
  • The American Journal of Human Genetics, Vol. 103, Issue 6
  • DOI: 10.1016/j.ajhg.2018.10.025

HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope
journal, March 2018


Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection
journal, May 2018


Recent progress in broadly neutralizing antibodies to HIV
journal, October 2018


Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
journal, January 2020

  • Roskin, Krishna M.; Jackson, Katherine J. L.; Lee, Ji-Yeun
  • Nature Immunology, Vol. 21, Issue 2
  • DOI: 10.1038/s41590-019-0581-0

Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells
posted_content, May 2018

  • Phuong Tran, Thi Thu; Eichholz, Karsten; Amelio, Patrizia
  • bioRxiv
  • DOI: 10.1101/334508

Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
journal, June 2018

  • Yeung, Jennifer; Li, Wenjie; Holinstat, Michael
  • Pharmacological Reviews, Vol. 70, Issue 3
  • DOI: 10.1124/pr.117.014530

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
journal, March 2018

  • Cuadrado, Antonio; Manda, Gina; Hassan, Ahmed
  • Pharmacological Reviews, Vol. 70, Issue 2
  • DOI: 10.1124/pr.117.014753

Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
journal, December 2019


Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
journal, March 2017


HIV vaccine delayed boosting increases Env variable region 2–specific antibody effector functions
journal, January 2020


Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
journal, September 2018


Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates
journal, June 2019


HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
journal, November 2018


Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans
journal, December 2019


Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design
journal, August 2018


Advances in HIV-1 Vaccine Development
journal, April 2018

  • Gao, Yong; McKay, Paul; Mann, Jamie
  • Viruses, Vol. 10, Issue 4
  • DOI: 10.3390/v10040167

Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIVSF162P3N-Infected Rhesus Macaques
journal, May 2018

  • Jia, Manxue; Lu, Hong; Kong, Xiang-Peng
  • Viruses, Vol. 10, Issue 5
  • DOI: 10.3390/v10050262

Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies
journal, January 2020


OUTRIDER: A statistical method for detecting aberrantly expressed genes in RNA sequencing data
posted_content, June 2018

  • Brechtmann, Felix; Matusevičiūtė, Agnė; Mertes, Christian
  • bioRxiv
  • DOI: 10.1101/322149

The developing premature infant gut microbiome is a major factor shaping the microbiome of neonatal intensive care unit rooms
journal, June 2018


Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
text, January 2017

  • Hua-Xin, Liao,; R., Mascola, John; Amanda, Eaton,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/8pms-aw04

Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells
journal, August 2018


Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire
journal, April 2018


Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine
journal, May 2018


Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
journal, April 2020


Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
journal, September 2018


Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates
journal, June 2019


Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans
journal, December 2019


Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design
journal, August 2018


Techniques to Study Antigen-Specific B Cell Responses
journal, July 2019


Advances in HIV-1 Vaccine Development
journal, April 2018

  • Gao, Yong; McKay, Paul; Mann, Jamie
  • Viruses, Vol. 10, Issue 4
  • DOI: 10.3390/v10040167

Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIVSF162P3N-Infected Rhesus Macaques
journal, May 2018

  • Jia, Manxue; Lu, Hong; Kong, Xiang-Peng
  • Viruses, Vol. 10, Issue 5
  • DOI: 10.3390/v10050262